CoChat

Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer

Open access
Sonkar, Kanchan, Ayyappan, Vinay, Tressler, Caitlin M., Adelaja, Oluwatobi, Cai, Ruoqing, Cheng, Menglin, Glunde, Kristine · 2019 · NMR in Biomedicine
Cited by 205

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Activated choline metabolism is a hallmark of carcinogenesis and tumor progression, which leads to elevated levels of phosphocholine and glycerophosphocholine in all types of cancer tested so far. Magnetic resonance spectroscopy applications have played a key role in detecting these elevated choline phospholipid metabolites. To date, the majority of cancer‐related studies have focused on phosphocholine and the Kennedy pathway, which constitutes the biosynthesis pathway for membrane phosphatidylcholine. Fewer and more recent studies have reported on the importance of glycerophosphocholine in cancer. In this review article, we summarize the recent literature on glycerophosphocholine metabolism with respect to its cancer biology and its detection by magnetic resonance spectroscopy applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/nbm.4112

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 328

  1. 10.1038/nature12626 · DOI · Paper page
  2. 10.1097/PPO.0000000000000127 · DOI
  3. 10.1038/nrc1782 · DOI · Paper page
  4. 10.18632/oncotarget.13907 · DOI · Paper page
  5. 10.1016/j.redox.2017.04.018 · DOI · Paper page
  6. 10.1016/j.cell.2011.02.013 · DOI · Paper page
  7. 10.1007/BF01114871 · DOI
  8. Daly PF, 1987, Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy, J Biol Chem., 262, 14875, 10.1016/S0021-9258(18)48107-0 · DOI · Paper page
  9. Aboagye EO, 1999, Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells, Cancer Res., 59, 80
  10. 10.1002/jmri.10181 · DOI · Paper page
  11. 10.1002/ijc.23552 · doi:10.1002/ijc.23552
  12. 10.1002/mrm.10654 · doi:10.1002/mrm.10654
  13. 10.1155/2004/424395 · DOI
  14. 10.1371/journal.pone.0180263 · DOI
  15. 10.1038/nrc3162 · DOI · Paper page
  16. 10.1002/jmri.10427 · DOI · Paper page
  17. 10.1148/radiol.2332031285 · DOI
  18. 10.1038/sj.bjc.6602948 · DOI
  19. 10.1148/radiol.2512080553 · DOI
  20. 10.1111/j.1471-0528.2008.02007.x · DOI
  21. 10.1002/jmri.10172 · DOI
  22. Ackerstaff E, 2001, Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells, Cancer Res., 61, 3599
  23. 10.1007/s10910-016-0694-8 · DOI
  24. 10.1002/nbm.3097 · DOI
  25. 10.1016/j.ijrobp.2012.01.020 · doi:10.1016/j.ijrobp.2012.01.020
  26. 10.1016/S0730-725X(01)00225-9 · doi:10.1016/s0730-725x(01)00225-9
  27. 10.1158/0008-5472.CAN-13-2409 · DOI
  28. 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U · DOI · Paper page
  29. 10.1158/0008-5472.CAN-05-1146 · DOI · Paper page
  30. 10.1002/nbm.1762 · DOI
  31. 10.1016/j.mric.2013.04.008 · DOI
  32. 10.1002/jmri.25560 · doi:10.1002/jmri.25560
  33. 10.1002/nbm.3684 · doi:10.1002/nbm.3684
  34. 10.1021/acs.biochem.7b01257 · doi:10.1021/acs.biochem.7b01257
  35. 10.1038/onc.2011.332 · DOI
  36. 10.1038/oncsis.2013.2 · doi:10.1038/oncsis.2013.2
  37. 10.1002/nbm.3429 · DOI
  38. 10.1016/0968-0004(88)90145-4 · doi:10.1016/0968-0004(88)90145-4
  39. 10.1016/S0021-9258(19)50785-2 · DOI · Paper page
  40. Cuadrado A, 1993, Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors, Oncogene., 8, 2959
  41. 10.1002/jcb.240570114 · DOI
  42. Price BD, 1989, Stimulation of phosphatidylcholine hydrolysis, diacylglycerol release, and arachidonic acid production by oncogenic ras is a consequence of protein kinase C activation, J Biol Chem., 264, 16638, 10.1016/S0021-9258(19)84753-1 · DOI
  43. 10.1073/pnas.83.18.6785 · DOI
  44. 10.1016/0005-2760(88)90114-2 · DOI
  45. 10.1007/BF02532834 · DOI
  46. 10.1074/jbc.272.31.19214 · doi:10.1074/jbc.272.31.19214
  47. 10.1002/nbm.2766 · DOI
  48. 10.1111/febs.12699 · DOI
  49. 10.1074/jbc.M110.106708 · DOI
  50. 10.3390/ijms12010588 · DOI · Paper page
  51. 10.1007/s11805-011-0562-z · DOI
  52. 10.1007/s10557-008-6132-9 · DOI · Paper page
  53. Kita Y, 1761, Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s, Biochim Biophys Acta Mol Cell Biol Lipids., 2006, 1317
  54. 10.1038/nrc2809 · DOI · Paper page
  55. 10.1194/jlr.R057588 · DOI · Paper page
  56. Bocca C, 2014, COX2 inhibitor NS398 reduces HT‐29 cell invasiveness by modulating signaling pathways mediated by egfr and HIF1‐α, Anticancer Res., 34, 1793
  57. Nakanishi M, 1761, Roles of cPLA2α and arachidonic acid in cancer, Biochim Biophys Acta., 2006, 1335
  58. 10.1210/me.2009-0293 · DOI
  59. 10.1038/sj.bjc.6606025 · DOI
  60. 10.1007/s12017-009-8092-z · DOI · Paper page
  61. 10.1074/jbc.274.13.8823 · DOI · Paper page
  62. 10.1002/jlb.65.3.330 · DOI · Paper page
  63. 10.1371/journal.pone.0045025 · DOI
  64. 10.1007/s00428-012-1227-x · DOI
  65. 10.1007/s10585-011-9404-x · DOI
  66. 10.1038/37622 · DOI · Paper page
  67. 10.2174/1568009615666150706103234 · DOI
  68. 10.1074/jbc.M807282200 · DOI
  69. 10.1016/j.canlet.2011.02.015 · doi:10.1016/j.canlet.2011.02.015
  70. Kisslov L, 1821, HT‐29 human colon cancer cell proliferation is regulated by cytosolic phospholipase A2α dependent PGE2 via both PKA and PKB pathways, Biochim Biophys Acta Mol Cell Biol Lipids., 2012, 1224
  71. 10.1016/j.plefa.2009.11.005 · DOI
  72. 10.1242/jcs.00446 · DOI
  73. 10.1038/cddis.2017.152 · DOI
  74. 10.1158/1078-0432.CCR-08-0566 · DOI
  75. 10.1093/jnci/djq290 · DOI
  76. 10.1074/jbc.274.24.17063 · DOI
  77. 10.1186/1471-2407-10-433 · DOI · Paper page
  78. 10.1021/bc200242v · doi:10.1021/bc200242v
  79. 10.1021/bc100271v · doi:10.1021/bc100271v
  80. 10.1021/acs.bioconjchem.5b00417 · DOI
  81. 10.1016/0005-2736(80)90574-X · DOI · Paper page
  82. 10.1016/j.biochi.2006.09.021 · DOI · Paper page
  83. 10.1016/S1388-1981(99)00063-3 · DOI
  84. 10.1042/bj3080551 · doi:10.1042/bj3080551
  85. 10.1042/bj2880831 · doi:10.1042/bj2880831
  86. 10.1073/pnas.73.5.1586 · doi:10.1073/pnas.73.5.1586
  87. Kelly RA, 1986, Identification of NaK‐ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids, J Biol Chem., 261, 11704, 10.1016/S0021-9258(18)67301-6 · DOI · Paper page
  88. 10.1186/s13071-017-2228-z · DOI
  89. Larson TJ, 1983, Periplasmic glycerophosphodiester phosphodiesterase of Escherichia coli , a new enzyme of the glp regulon, J Biol Chem., 258, 5428, 10.1016/S0021-9258(20)81908-5 · DOI · Paper page
  90. 10.1042/bj0620689 · doi:10.1042/bj0620689
  91. 10.1073/pnas.88.17.7820 · DOI
  92. 10.1073/pnas.0805496105 · DOI
  93. 10.1073/pnas.1117654109 · DOI
  94. 10.1074/jbc.M114.614537 · DOI
  95. 10.1016/j.ccell.2016.08.016 · DOI
  96. 10.18632/oncotarget.14233 · DOI
  97. 10.1002/nbm.3106 · DOI
  98. 10.1002/nbm.3573 · DOI
  99. 10.1016/j.neo.2017.05.004 · doi:10.1016/j.neo.2017.05.004
  100. 10.1128/MCB.9.1.325 · DOI
  101. 10.1038/sj.onc.1205144 · doi:10.1038/sj.onc.1205144
  102. 10.1080/10408360290795538 · DOI · Paper page
  103. 10.1016/S0092-8674(00)81764-X · DOI · Paper page
  104. 10.3390/cancers7030860 · DOI · Paper page
  105. 10.1101/cshperspect.a011254 · DOI · Paper page
  106. 10.7150/ijms.1.101 · DOI · Paper page
  107. Katz M, 1773, Regulation of MAPKs by growth factors and receptor tyrosine kinases, Biochim Biophys Acta., 2007, 1161
  108. 10.1038/358417a0 · DOI · Paper page
  109. 10.1074/jbc.M212803200 · DOI · Paper page
  110. 10.1016/j.ctrv.2014.02.008 · DOI · Paper page
  111. 10.1096/fasebj.6.6.1312047 · DOI · Paper page
  112. 10.1634/theoncologist.8-6-531 · DOI · Paper page
  113. 10.1038/nrc3093 · DOI · Paper page
  114. 10.1016/0092-8674(87)90581-2 · DOI · Paper page
  115. 10.1210/er.20.3.321 · DOI
  116. 10.1126/science.1071884 · DOI · Paper page
  117. 10.1097/00001703-199906000-00003 · DOI
  118. 10.1186/bcr79 · DOI
  119. 10.1007/s00018-003-3222-5 · DOI
  120. 10.1126/science.1132509 · DOI
  121. 10.1186/1471-2407-10-629 · DOI
  122. 10.1158/0008-5472.CAN-09-3834 · DOI
  123. 10.1210/en.2009-1506 · DOI
  124. 10.1093/annonc/mdn291 · DOI · Paper page
  125. 10.1023/A:1023777013659 · DOI · Paper page
  126. 10.1073/pnas.0308319100 · DOI · Paper page
  127. 10.1016/j.steroids.2009.02.005 · DOI
  128. 10.1016/S0002-9440(10)64702-5 · DOI · Paper page
  129. 10.1016/j.ccr.2010.02.030 · DOI · Paper page
  130. 10.1530/rep.1.00189 · DOI · Paper page
  131. 10.1016/j.jmb.2016.06.020 · DOI · Paper page
  132. 10.1016/j.mce.2011.10.030 · DOI · Paper page
  133. 10.1210/me.2005-0242 · DOI · Paper page
  134. 10.1186/bcr452 · DOI · Paper page
  135. 10.1023/A:1015718406329 · DOI
  136. Frech MS, 2005, Deregulated estrogen receptor α expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ, Cancer Res., 65, 681, 10.1158/0008-5472.681.65.3 · doi:10.1158/0008-5472.681.65.3
  137. Medina D, 2003, Hormone dependence in premalignant mammary progression, Cancer Res., 63, 1067
  138. 10.1210/en.2008-1630 · DOI
  139. 10.1016/S0002-9440(10)65498-3 · DOI · Paper page
  140. 10.1073/pnas.0915148107 · DOI · Paper page
  141. 10.1007/s10549-014-3049-9 · DOI
  142. 10.1186/s13058-015-0538-7 · DOI · Paper page
  143. Bhatia P, 2005, Expression of receptor activator of Nuclear Factor‐κB ligand is inversely correlated with metastatic phenotype in breast carcinoma, Clin Cancer Res., 11, 162, 10.1158/1078-0432.162.11.1 · DOI · Paper page
  144. 10.1158/1078-0432.CCR-06-1732 · DOI
  145. 10.1126/science.2470152 · DOI · Paper page
  146. 10.1186/bcr327 · DOI · Paper page
  147. 10.1155/2012/743193 · DOI · Paper page
  148. 10.1128/MCB.6.3.955 · DOI · Paper page
  149. 10.1128/MCB.6.5.1729 · DOI · Paper page
  150. 10.1126/science.3012781 · DOI · Paper page
  151. 10.1007/s10549-011-1606-z · DOI
  152. 10.1097/PDM.0b013e31818cbdb2 · DOI
  153. 10.1016/j.ejca.2005.11.012 · DOI
  154. 10.1007/s12282-007-0026-8 · doi:10.1007/s12282-007-0026-8
  155. 10.1038/sj.onc.1202091 · DOI
  156. Ramić S, 2013, Correlation of phosphorylated HER2 with clinicopathological characteristics and efficacy of trastuzumab treatment for breast cancer, Anticancer Res., 33, 2509
  157. 10.1021/pr9008783 · DOI · Paper page
  158. 10.1038/nrc839 · DOI · Paper page
  159. 10.1128/MCB.01917-07 · DOI · Paper page
  160. 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
  161. 10.1016/S0065-230X(09)02001-6 · DOI · Paper page
  162. 10.1038/nrc969 · DOI · Paper page
  163. Bos JL, 1989, ras oncogenes in human cancer: A review, Cancer Res., 49, 4682
  164. 10.1016/S0962-8924(00)01740-2 · DOI · Paper page
  165. 10.1146/annurev.bi.62.070193.004223 · DOI · Paper page
  166. 10.1101/gad.11.19.2468 · DOI · Paper page
  167. Colicelli J, 2004, Human RAS superfamily proteins and related GTPases, Sci. STKE, 2004, 10.1126/stke.2502004re13 · DOI · Paper page
  168. 10.1074/jbc.M115.656710 · DOI
  169. 10.1016/S0304-419X(99)00007-4 · DOI
  170. 10.1016/0092-8674(90)90294-O · DOI · Paper page
  171. 10.1158/0008-5472.CAN-13-1750 · DOI · Paper page
  172. 10.1038/369411a0 · DOI · Paper page
  173. 10.2174/1381612013397258 · DOI
  174. 10.1146/annurev.biochem.67.1.481 · DOI · Paper page
  175. 10.1016/j.ctrv.2003.07.007 · DOI · Paper page
  176. 10.1038/sj.onc.1209087 · DOI · Paper page
  177. 10.3389/fonc.2014.00064 · DOI · Paper page
  178. 10.3892/ijo.2016.3804 · DOI
  179. 10.1158/1535-7163.MCT-03-0220 · DOI
  180. 10.1002/nbm.1764 · DOI
  181. 10.2119/molmed.2011.00315 · doi:10.2119/molmed.2011.00315
  182. Singh S, 1799, Small molecule regulators of Rb–E2F pathway as modulators of transcription, Biochim Biophys Acta Gene Regul Mech., 2010, 788
  183. 10.1002/ijc.25181 · DOI
  184. Özcan S, 1799, Modulation of transcription factor function by O‐GlcNAc modification, Biochim Biophys Acta Gene Regul Mech., 2010, 353
  185. 10.1038/nature09607 · DOI
  186. 10.1371/journal.pgen.1002112 · DOI
  187. 10.1038/emboj.2011.159 · DOI
  188. 10.1200/jco.2011.29.15_suppl.599 · doi:10.1200/jco.2011.29.15_suppl.599
  189. 10.1158/0008-5472.CAN-09-1530 · DOI
  190. 10.1038/onc.2010.43 · DOI
  191. 10.1158/0008-5472.CAN-10-2330 · DOI · Paper page
  192. 10.1200/jco.2011.29.15_suppl.623 · doi:10.1200/jco.2011.29.15_suppl.623
  193. 10.1097/CAD.0b013e328341185b · DOI
  194. 10.1038/s41375-018-0117-x · DOI · Paper page
  195. 10.1158/0008-5472.CAN-10-2626 · DOI · Paper page
  196. 10.1016/j.bcp.2010.03.026 · DOI · Paper page
  197. 10.1158/0008-5472.CAN-07-2678 · DOI
  198. 10.1593/neo.12858 · DOI
  199. 10.18632/oncotarget.24569 · DOI
  200. 10.1111/j.1742-4658.2012.08644.x · DOI · Paper page

200 of 328 shown

Cited by

See all 205

Metadata

Authors
Sonkar, K., Ayyappan, V., Tressler, C. M., Adelaja, O., Cai, R., Cheng, M., & Glunde, K.
Venue
NMR in Biomedicine
Publisher
Wiley
Published
2019-06-11
Volume
32
Issue
10
Pages
e4112-e4112
ISSN
  • 0952-3480 (ISSN-L)
  • 1099-1492
OpenAlex
W2949840475
Cited by
205
References
10
FWCI
3.94
Type
journal article
Language
en
Open access
green
Funders
National Cancer Institute (R01 CA213428, R01 CA213492)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.